Swiss pharma company Acino deepens its footprint in Saudi with new Jeddah office

By Arya M Nair, Intern Reporter
  • Follow author on
Pharma Sector
Representational Image

Acino, a Switzerland-based pharmaceutical company, has expanded into the Kingdom of Saudi Arabia by establishing a legal entity and office in Jeddah.

The move is part of the company’s growth strategy in the Middle East, Turkey and Africa (META) region, as part of its aim to provide patients with access to high-quality medicines. The announcement was made during an event that took place at the office of the Ministry of Investment of Saudi Arabia (MISA).

Acino made its entry to the Kingdom by setting up a scientific office in 2017. The decision to expand further in the country follows a significant demand for its products and services. The company’s plans include bringing global expertise to Saudi as well as hiring nationals as part of its investments in human resources and scientific activities.

Acino will also explore opportunities to collaborate with local manufacturers and produce select medications in the country. The Jeddah office will serve its mission to bring access to high-quality affordable medicines to both national and expatriate patients, as well as support the country’s upcoming Health Sector Transformation Program as part of the National Vision 2030.

Dr. Sara Althari
Dr. Sara Althari
Managing Director
Biotech & Pharma
MISA

“Biotechnology and healthcare are at the forefront of our national priorities, and we are committed to partnering with global pharmaceutical companies to bring the highest quality care and industry expertise to the Kingdom. We welcome the expansion of Acino’s operations and footprint in the Kingdom and are deeply encouraged by the company’s commitment to invest in our healthcare ecosystem.”

Mr. Steffen Saltofte, CEO of Acino said that “Acino has committed to the world to advance the development of healthcare by accelerating time-to-market and patient access to high-quality medicines that all stakeholders can trust. We work closely with health ministries, manufacturers, and a broad range of healthcare professionals to enhance the quality of care and improve treatment outcomes. Our arrival in Saudi Arabia has received warm support from the Ministry of Investment and builds on the renewed momentum from the KSA government in its plans to enhance the healthcare sector.”

Related: Saudi’s Nahdi Medical opens MENA’s 1st smart retail pharma facility


YOU MAY LIKE